Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Identification of Myocardial Insulin Resistance by Using Liver Tests: A Simple Approach for Clinical Practice

  • Herance Camacho, José Raul
  • Martin Saladich, Queralt
  • Velasquez Arevalo, Mayra Alejandra
  • Hernández Pascual, Cristina
  • Aparicio Gomez, Carolina
  • Ramírez Serra, Clara
  • Ferrer Costa, Roser
  • Pericàs Pulido, Juan Manuel
  • Castell Conesa, Joan
  • Aguade Bruix, Santiago
  • Simó Canonge, Rafael
  • Giralt Arnaiz, Marina
  • González Ballester, Miguel Ángel
Cardiovascular risk; Myocardial insulin resistance; Non-alcoholic fatty liver disease, Riesgo cardiovascular; Resistencia a la insulina del miocardio; Enfermedad del higado graso no alcoholico, Risc cardiovascular; Resistència a la insulina del miocardi; Malaltia del fetge gras no alcohòlic, Background: We report that myocardial insulin resistance (mIR) occurs in around 60% of patients with type 2 diabetes (T2D) and was associated with higher cardiovascular risk in comparison with patients with insulin-sensitive myocardium (mIS). These two phenotypes (mIR vs. mIS) can only be assessed using time-consuming and expensive methods. The aim of the present study is to search a simple and reliable surrogate to identify both phenotypes. Methods: Forty-seven patients with T2D underwent myocardial [18F]FDG PET/CT at baseline and after a hyperinsulinemic–euglycemic clamp (HEC) to determine mIR were prospectively recruited. Biochemical assessments were performed before and after the HEC. Baseline hepatic steatosis index and index of hepatic fibrosis (FIB-4) were calculated. Furthermore, liver stiffness measurement was performed using transient elastography. Results: The best model to predict the presence of mIR was the combination of transaminases, protein levels, FIB-4 score and HOMA (AUC = 0.95; sensibility: 0.81; specificity: 0.95). We observed significantly higher levels of fibrosis in patients with mIR than in those with mIS (p = 0.034). In addition, we found that patients with mIR presented a reduced glucose uptake by the liver in comparison with patients with mIS. Conclusions: The combination of HOMA, protein, transaminases and FIB-4 is a simple and reliable tool for identifying mIR in patients with T2D. This information will be useful to improve the stratification of cardiovascular risk in T2D., This work was supported by the Carlos III Health Institute and the European Regional Development Fund (PI16/02064, PI20/01588) and the Agency for Management of University and Research Grants (AGAUR) of Catalonia (2017SGR1303).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Phenotyping Type 2 Diabetes in Terms of Myocardial Insulin Resistance and Its Potential Cardiovascular Consequences: A New Strategy Based on 18F-FDG PET/CT

  • Herance Camacho, José Raul
  • Velasquez Arevalo, Mayra Alejandra
  • Garcia León, Daniel
  • Aparicio Gomez, Carolina
  • Marès Pagès, Roso
  • Simó-Servat, Olga
  • Castell Conesa, Joan
  • Hernández Pascual, Cristina
  • Aguade Bruix, Santiago
  • Simó Canonge, Rafael
  • Paun, Bruno
Cardiovascular risk; Myocardial insulin resistance; Type 2 diabetes, Risc cardiovascular; Resistència miocàrdica a la insulina; Diabetis tipus 2, Riesgo cardiovascular; Resistencia miocárdica a la insulina; Diabetes tipo 2, Background: Systemic insulin resistance is generally postulated as an independent risk factor of cardiovascular events in type 2 diabetes (T2D). However, the role of myocardial insulin resistance (mIR) remains to be clarified. Methods: Two 18F-FDG PET/CT scans were performed on forty-three T2D patients at baseline and after hyperinsulinemic–euglycemic clamp (HEC). Myocardial insulin sensitivity (mIS) was determined by measuring the increment in myocardial 18F-FDG uptake after HEC. Coronary artery calcium scoring (CACs) and myocardial radiodensity (mRD) were assessed by CT. Results: After HEC, seventeen patients exhibited a strikingly enhancement of myocardial 18F-FDG uptake and twenty-six a marginal increase, thus revealing mIS and mIR, respectively. Patients with mIR showed higher mRD (HU: 38.95 [33.81–44.06] vs. 30.82 [21.48–38.02]; p = 0.03) and CACs > 400 (AU: 52% vs. 29%; p = 0.002) than patients with mIS. In addition, HOMA-IR and mIS only showed a correlation in those patients with mIR. Conclusions: 18F-FDG PET combined with HEC is a reliable method for identifying patients with mIR. This subgroup of patients was found to be specifically at high risk of developing cardiovascular events and showed myocardial structural changes. Moreover, the gold-standard HOMA-IR index was only associated with mIR in this subgroup of patients. Our results open up a new avenue for stratifying patients with cardiovascular risk in T2D., This research was funded by the Carlos III Health Institute and the European Regional Development Fund (PI16/02064 and PI20/01588) and AGAUR (2017SGR1303 and 2017SGR1144).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Modelling the skeletal muscle injury recovery using in vivo contrast-enhanced micro-CT, a proof-of-concept study in a rat model

  • Paun, Bruno
  • García Leon, Daniel|||0000-0001-7199-3079
  • Claveria Cabello, Alex
  • Marés, Roso|||0000-0002-7339-0172
  • de la Calle Vargas, Elena|||0000-0001-9717-9622
  • Contreras Muñoz, Paola
  • Venegas García, Vanessa
  • Castell-Conesa, Joan|||0000-0002-6449-9731
  • Marotta, Mario|||0000-0003-4933-0572
  • Herance, José Raul|||0000-0001-7178-3290
Skeletal muscle injury characterisation during healing supports trauma prognosis. Given the potential interest of computed tomography (CT) in muscle diseases and lack of in vivo CT methodology to image skeletal muscle wound healing, we tracked skeletal muscle injury recovery using in vivo micro-CT in a rat model to obtain a predictive model. Skeletal muscle injury was performed in 23 rats. Twenty animals were sorted into five groups to image lesion recovery at 2, 4, 7, 10, or 14 days after injury using contrast-enhanced micro-CT. Injury volumes were quantified using a semiautomatic image processing, and these values were used to build a prediction model. The remaining 3 rats were imaged at all monitoring time points as validation. Predictions were compared with Bland-Altman analysis. Optimal contrast agent dose was found to be 20 mL/kg injected at 400 μL/min. Injury volumes showed a decreasing tendency from day 0 (32.3 ± 12.0mm 3, mean ± standard deviation) to day 2, 4, 7, 10, and 14 after injury (19.6 ± 12.6, 11.0 ± 6.7, 8.2 ± 7.7, 5.7 ± 3.9, and 4.5 ± 4.8 mm 3, respectively). Groups with single monitoring time point did not yield significant differences with the validation group lesions. Further exponential model training with single follow-up data (R 2 = 0.968) to predict injury recovery in the validation cohort gave a predictions root mean squared error of 6.8 ± 5.4 mm 3. Further prediction analysis yielded a bias of 2.327. Contrast-enhanced CT allowed in vivo tracking of skeletal muscle injury recovery in rat.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Phenotyping Type 2 Diabetes in Terms of Myocardial Insulin Resistance and Its Potential Cardiovascular Consequences, A New Strategy Based on 18 F-FDG PET/CT

  • Herance, José Raul|||0000-0001-7178-3290
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Velasquez, Mayra Alejandra
  • Paun, Bruno
  • García Leon, Daniel|||0000-0001-7199-3079
  • Aparicio-Gómez, Carolina|||0000-0002-0845-2365
  • Marés, Roso|||0000-0002-7339-0172
  • Simó-Servat, Olga|||0000-0003-3483-652X
  • Castell-Conesa, Joan|||0000-0002-6449-9731
  • Hernández, Cristina|||0000-0002-3109-1721
  • Aguadé-Bruix, Santiago|||0000-0001-8617-6274
Background: Systemic insulin resistance is generally postulated as an independent risk factor of cardiovascular events in type 2 diabetes (T2D). However, the role of myocardial insulin resistance (mIR) remains to be clarified. Methods: Two 18 F-FDG PET/CT scans were performed on forty-three T2D patients at baseline and after hyperinsulinemic-euglycemic clamp (HEC). Myocardial insulin sensitivity (mIS) was determined by measuring the increment in myocardial 18 F-FDG uptake after HEC. Coronary artery calcium scoring (CACs) and myocardial radiodensity (mRD) were assessed by CT. Results: After HEC, seventeen patients exhibited a strikingly enhancement of myocardial 18 F-FDG uptake and twenty-six a marginal increase, thus revealing mIS and mIR, respectively. Patients with mIR showed higher mRD (HU: 38.95 [33.81-44.06] vs. 30.82 [21.48-38.02]; p = 0.03) and CACs.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Assessment of gold nanoparticles on human peripheral blood cells by metabolic profiling with 1 H-NMR spectroscopy, a novel translational approach on a patient-specific basis

  • Palomino-Schätzlein, Martina
  • García, Hermenegildo|||0000-0002-9664-493X
  • Gutiérrez-Carcedo, Patricia|||0000-0001-8903-2380
  • Pineda-Lucena, Antonio
  • Herance, José Raul|||0000-0001-7178-3290
Human peripheral blood cells are relevant ex vivo models for characterizing diseases and evaluating the pharmacological effects of therapeutic interventions, as they provide a close reflection of an individual pathophysiological state. In this work, a new approach to evaluate the impact of nanoparticles on the three main fractions of human peripheral blood cells by nuclear magnetic resonance spectroscopy is shown. Thus, a comprehensive protocol has been set-up including the separation of blood cells, their in vitro treatment with nanoparticles and the extraction and characterization of metabolites by nuclear magnetic resonance. This method was applied to assess the effect of gold nanoparticles, either coated with chitosan or supported on ceria, on peripheral blood cells from healthy individuals. A clear antioxidant effect was observed for chitosan-coated gold nanoparticles by a significant increase in reduced glutathione, that was much less pronounced for gold-cerium nanoparticles. In addition, the analysis revealed significant alterations of several other pathways, which were stronger for gold-cerium nanoparticles. These results are in accordance with the toxicological data previously reported for these materials, confirming the value of the current methodology.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Footprint of Type 1 Diabetes on Red Blood Cells, A Metabolomic and Lipidomic Study

  • Herance, José Raul|||0000-0001-7178-3290
  • Ciudin, Andreea|||0000-0001-5622-0203
  • Lamas-Domingo, Rubén
  • Aparicio-Gómez, Carolina|||0000-0002-0845-2365
  • Hernández, Cristina|||0000-0002-3109-1721
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Palomino-Schätzlein, Martina
The prevalence of diabetes type 1 (T1D) in the world populations is continuously growing. Although treatment methods are improving, the diagnostic is still symptom-based and sometimes far after onset of the disease. In this context, the aim of the study was the search of new biomarkers of the disease in red blood cells (RBCs), until now unexplored. The metabolomic and the lipidomic profile of RBCs from T1D patients and matched healthy controls was determined by NMR spectroscopy, and different multivariate discrimination models were built to select the metabolites and lipids that change most significantly. Relevant metabolites were further confirmed by univariate statistical analysis. Robust separation in the metabolomic and lipidomic profiles of RBCs from patients and controls was confirmed by orthogonal projection on latent structure discriminant analysis (OPLS-DA), random forest analysis, and significance analysis of metabolites (SAM). The main changes were detected in the levels of amino acids, organic acids, creatine and phosphocreatine, lipid change length, and choline derivatives, demonstrating changes in glycolysis, BCAA metabolism, and phospholipid metabolism. Our study proves that robust differences exist in the metabolic and lipidomic profile of RBCs from T1D patients, in comparison with matched healthy individuals. Some changes were similar to alterations found already in RBCs of T2D patients, but others seemed to be specific for type 1 diabetes. Thus, many of the metabolic differences found could be biomarker candidates for an earlier diagnosis or monitoring of patients with T1D.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Identification of Myocardial Insulin Resistance by Using Liver Tests, A Simple Approach for Clinical Practice

  • Herance, José Raul|||0000-0001-7178-3290
  • Martín-Saladich, Queralt|||0000-0003-4798-1558
  • Velásquez, Mayra Alejandra
  • Hernández, Cristina|||0000-0002-3109-1721
  • Aparicio-Gómez, Carolina|||0000-0002-0845-2365
  • Ramírez Serra, Clara|||0000-0001-8971-1711
  • Ferrer Costa, Roser|||0000-0002-8925-3172
  • Giralt-Arnaiz, Marina
  • González Ballester, Miguel Ángel|||0000-0002-9227-6826
  • Pericàs, Juan M.|||0000-0002-3645-3293
  • Castell-Conesa, Joan|||0000-0002-6449-9731
  • Aguadé-Bruix, Santiago|||0000-0001-8617-6274
  • Simó Canonge, Rafael|||0000-0003-0475-3096
Background: We report that myocardial insulin resistance (mIR) occurs in around 60% of patients with type 2 diabetes (T2D) and was associated with higher cardiovascular risk in comparison with patients with insulin-sensitive myocardium (mIS). These two phenotypes (mIR vs. mIS) can only be assessed using time-consuming and expensive methods. The aim of the present study is to search a simple and reliable surrogate to identify both phenotypes. Methods: Forty-seven patients with T2D underwent myocardial [18F]FDG PET/CT at baseline and after a hyperinsulinemic-euglycemic clamp (HEC) to determine mIR were prospectively recruited. Biochemical assessments were performed before and after the HEC. Baseline hepatic steatosis index and index of hepatic fibrosis (FIB-4) were calculated. Furthermore, liver stiffness measurement was performed using transient elastography. Results: The best model to predict the presence of mIR was the combination of transaminases, protein levels, FIB-4 score and HOMA (AUC = 0.95; sensibility: 0.81; specificity: 0.95). We observed significantly higher levels of fibrosis in patients with mIR than in those with mIS (p = 0.034). In addition, we found that patients with mIR presented a reduced glucose uptake by the liver in comparison with patients with mIS. Conclusions: The combination of HOMA, protein, transaminases and FIB-4 is a simple and reliable tool for identifying mIR in patients with T2D. This information will be useful to improve the stratification of cardiovascular risk in T2D.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Identification of Myocardial Insulin Resistance by Using Liver Tests: A Simple Approach for Clinical Practice

  • Herance Camacho, José Raul
  • Martin Saladich, Queralt
  • Velasquez Arevalo, Mayra Alejandra
  • Hernández Pascual, Cristina
  • Aparicio Gomez, Carolina
  • Ramírez Serra, Clara
  • Ferrer Costa, Roser
  • Pericàs Pulido, Juan Manuel
  • Castell Conesa, Joan
  • Aguade Bruix, Santiago
  • Simó Canonge, Rafael
  • Giralt Arnaiz, Marina
  • González Ballester, Miguel Ángel
Cardiovascular risk; Myocardial insulin resistance; Non-alcoholic fatty liver disease, Riesgo cardiovascular; Resistencia a la insulina del miocardio; Enfermedad del higado graso no alcoholico, Risc cardiovascular; Resistència a la insulina del miocardi; Malaltia del fetge gras no alcohòlic, Background: We report that myocardial insulin resistance (mIR) occurs in around 60% of patients with type 2 diabetes (T2D) and was associated with higher cardiovascular risk in comparison with patients with insulin-sensitive myocardium (mIS). These two phenotypes (mIR vs. mIS) can only be assessed using time-consuming and expensive methods. The aim of the present study is to search a simple and reliable surrogate to identify both phenotypes. Methods: Forty-seven patients with T2D underwent myocardial [18F]FDG PET/CT at baseline and after a hyperinsulinemic–euglycemic clamp (HEC) to determine mIR were prospectively recruited. Biochemical assessments were performed before and after the HEC. Baseline hepatic steatosis index and index of hepatic fibrosis (FIB-4) were calculated. Furthermore, liver stiffness measurement was performed using transient elastography. Results: The best model to predict the presence of mIR was the combination of transaminases, protein levels, FIB-4 score and HOMA (AUC = 0.95; sensibility: 0.81; specificity: 0.95). We observed significantly higher levels of fibrosis in patients with mIR than in those with mIS (p = 0.034). In addition, we found that patients with mIR presented a reduced glucose uptake by the liver in comparison with patients with mIS. Conclusions: The combination of HOMA, protein, transaminases and FIB-4 is a simple and reliable tool for identifying mIR in patients with T2D. This information will be useful to improve the stratification of cardiovascular risk in T2D., This work was supported by the Carlos III Health Institute and the European Regional Development Fund (PI16/02064, PI20/01588) and the Agency for Management of University and Research Grants (AGAUR) of Catalonia (2017SGR1303).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Phenotyping Type 2 Diabetes in Terms of Myocardial Insulin Resistance and Its Potential Cardiovascular Consequences: A New Strategy Based on 18F-FDG PET/CT

  • Herance Camacho, José Raul
  • Velasquez Arevalo, Mayra Alejandra
  • Garcia León, Daniel
  • Aparicio Gomez, Carolina
  • Marès Pagès, Roso
  • Simó Servat, Olga
  • Castell Conesa, Joan
  • Hernández Pascual, Cristina
  • Aguade Bruix, Santiago
  • Simó Canonge, Rafael
  • Paun, Bruno
Cardiovascular risk; Myocardial insulin resistance; Type 2 diabetes, Risc cardiovascular; Resistència miocàrdica a la insulina; Diabetis tipus 2, Riesgo cardiovascular; Resistencia miocárdica a la insulina; Diabetes tipo 2, Background: Systemic insulin resistance is generally postulated as an independent risk factor of cardiovascular events in type 2 diabetes (T2D). However, the role of myocardial insulin resistance (mIR) remains to be clarified. Methods: Two 18F-FDG PET/CT scans were performed on forty-three T2D patients at baseline and after hyperinsulinemic–euglycemic clamp (HEC). Myocardial insulin sensitivity (mIS) was determined by measuring the increment in myocardial 18F-FDG uptake after HEC. Coronary artery calcium scoring (CACs) and myocardial radiodensity (mRD) were assessed by CT. Results: After HEC, seventeen patients exhibited a strikingly enhancement of myocardial 18F-FDG uptake and twenty-six a marginal increase, thus revealing mIS and mIR, respectively. Patients with mIR showed higher mRD (HU: 38.95 [33.81–44.06] vs. 30.82 [21.48–38.02]; p = 0.03) and CACs > 400 (AU: 52% vs. 29%; p = 0.002) than patients with mIS. In addition, HOMA-IR and mIS only showed a correlation in those patients with mIR. Conclusions: 18F-FDG PET combined with HEC is a reliable method for identifying patients with mIR. This subgroup of patients was found to be specifically at high risk of developing cardiovascular events and showed myocardial structural changes. Moreover, the gold-standard HOMA-IR index was only associated with mIR in this subgroup of patients. Our results open up a new avenue for stratifying patients with cardiovascular risk in T2D., This research was funded by the Carlos III Health Institute and the European Regional Development Fund (PI16/02064 and PI20/01588) and AGAUR (2017SGR1303 and 2017SGR1144).